Sensus Healthcare (NASDAQ:SRTS) vs. Adagio Medical (NASDAQ:ADGM) Financial Comparison

Sensus Healthcare (NASDAQ:SRTS) and Adagio Medical (NASDAQ:ADGM) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, valuation, earnings and risk.

Profitability

This table compares Sensus Healthcare and Adagio Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-28.09%	-15.11%	-13.40%
Adagio Medical	N/A	-312.04%	-66.00%

Institutional and Insider Ownership

25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 8.9% of Sensus Healthcare shares are owned by company insiders. Comparatively, 5.2% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk and Volatility

Sensus Healthcare has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Adagio Medical has a beta of 0.04, indicating that its stock price is 96% less volatile than the S&P 500.

Valuation and Earnings

This table compares Sensus Healthcare and Adagio Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48 million	2.70	-$7.72 million	($0.47)	-9.60
Adagio Medical	N/A	N/A	-$25.08 million	($1.73)	-0.92

Sensus Healthcare has higher revenue and earnings than Adagio Medical. Sensus Healthcare is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current recommendations for Sensus Healthcare and Adagio Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1	1	4	0	2.50
Adagio Medical	1	0	2	0	2.33

Sensus Healthcare presently has a consensus target price of $6.88, indicating a potential upside of 52.44%. Adagio Medical has a consensus target price of $3.50, indicating a potential upside of 118.75%. Given Adagio Medical’s higher probable upside, analysts plainly believe Adagio Medical is more favorable than Sensus Healthcare.

Summary

Sensus Healthcare beats Adagio Medical on 9 of the 13 factors compared between the two stocks.

About Sensus Healthcare

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

About Adagio Medical

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.